Dr Jessica Salmon

Cancer Type: Leukaemia

Research: Additional therapies for patients with relapsed, refractory or secondary acute myeloid leukaemia (AML) that may be used in combination with chemotherapy to improve patient outcome

Institute: Peter MaCallum Cancer Centre

Supported by: Hays